Literature DB >> 27322569

Morphine Postconditioning Protects against Reperfusion Injury via Inhibiting JNK/p38 MAPK and Mitochondrial Permeability Transition Pores Signaling Pathways.

Zuolei Chen1, Xuewei Zhang, Yingzhi Liu, Zhongkai Liu.   

Abstract

BACKGROUND: The purpose of this study was to determine whether c-jun NH2 amino-terminal kinases (JNK) and p38 mitogen-activated protein kinases (MAPK) were involved in morphine postconditioning (MpostC).
METHODS: The isolated rat hearts were randomly assigned into one of the following groups. Hearts in the time control (TC) group were constantly perfused for 105min. Hearts in the ischemia-reperfusion (I/R) group were subjected to 45 min of ischemia followed by 1 h of reperfusion. MpostC was induced by 10 min of morphine administration at the onset of reperfusion. Anisomycin (an activator of JNK/p38 kinases) was administered with or without morphine during the first 10 min of reperfusion following the 45 min of ischemia. Mitochondria and cytosolic proteins were prepared to detect mitochondrial permeability transition (MPT) and cytochrome C (Cyt-c) respectively.
RESULTS: MpostC markedly reduced infarct size (IS/AAR), CK-MB release, and improved cardiac function recovery. However, these protective effects were partly abolished in the presence of anisomycin. I/R significantly increased the phosphorylation of JNK and p38 kinases, mitochondrial permeability transition (MPT) opening and Cyt-c release, while these effects were partly abolished by MpostC. The inhibitory effects of MpostC on the phosphorylation of JNK/p38 kinases, MPT opening and Cyt-c release were totally reversed by Anisocycin, which, used individually, did not show any influence on perfusion injury.
CONCLUSIONS: These findings suggest that MpostC protects isolated rat hearts against reperfusion injury via inhibiting JNK/p38 MAPKs and mitochondrial permeability transition pores signaling pathways.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27322569     DOI: 10.1159/000445605

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  5 in total

1.  Transforming Growth Factor-β Receptor III is a Potential Regulator of Ischemia-Induced Cardiomyocyte Apoptosis.

Authors:  Fei Sun; Xin Li; Wen-Qi Duan; Wei Tian; Ming Gao; Jia Yang; Xia-Yang Wu; Di Huang; Wei Xia; Yan-Na Han; Jia-Xin Wang; Yan-Xin Liu; Chang-Jiang Dong; Dan Zhao; Tao Ban; Wen-Feng Chu
Journal:  J Am Heart Assoc       Date:  2017-05-30       Impact factor: 5.501

2.  Toll-Like Receptor 4 (TLR4) Stimulates Synovial Injury of Temporomandibular Joint in Rats Through the Activation of p38 Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway.

Authors:  Xuefen Lin; Jianli Xie; Shuzhen Sun; Xusheng Ren; Jingjing Kong; Ping Ji
Journal:  Med Sci Monit       Date:  2018-06-26

Review 3.  c-Jun N-Terminal Kinases (JNKs) in Myocardial and Cerebral Ischemia/Reperfusion Injury.

Authors:  Maria Shvedova; Yana Anfinogenova; Elena N Atochina-Vasserman; Igor A Schepetkin; Dmitriy N Atochin
Journal:  Front Pharmacol       Date:  2018-07-05       Impact factor: 5.810

4.  Regulation of skeletal myogenesis in C2C12 cells through modulation of Pax7, MyoD, and myogenin via different low-frequency electromagnetic field energies.

Authors:  Jiaqi Bi; Hong Jing; ChenLiang Zhou; Peng Gao; Fujun Han; Gang Li; Shiwei Zhang
Journal:  Technol Health Care       Date:  2022       Impact factor: 1.205

5.  Long intergenic non-protein coding RNA 511 promotes the progression of osteosarcoma cells through sponging microRNA 618 to upregulate the expression of maelstrom.

Authors:  Wen Guo; Qing Yu; Ming Zhang; Fang Li; Yu Liu; Weiwei Jiang; Haitao Jiang; Haijun Li
Journal:  Aging (Albany NY)       Date:  2019-08-06       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.